Global Epigenetics Industry
Global Epigenetics Market to Reach $25. 6 Billion by 2027. Amid the COVID-19 crisis, the global market for Epigenetics estimated at US$7. 4 Billion in the year 2020, is projected to reach a revised size of US$25.
New York, Sept. 04, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Epigenetics Industry" - https://www.reportlinker.com/p05817986/?utm_source=GNW
6 Billion by 2027, growing at a CAGR of 19.5% over the analysis period 2020-2027. Reagents, one of the segments analyzed in the report, is projected to record a 19.9% CAGR and reach US$10.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits segment is readjusted to a revised 22.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $2.2 Billion, While China is Forecast to Grow at 18.8% CAGR
The Epigenetics market in the U.S. is estimated at US$2.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2027 trailing a CAGR of 18.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.3% and 16.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.4% CAGR.
Instruments Segment to Record 17.9% CAGR
In the global Instruments segment, USA, Canada, Japan, China and Europe will drive the 17.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$3.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2027.We bring years of research experience to this 16th edition of our report. The 234-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
· Abcam PLC
· Active Motif, Inc.
· CellCentric
· Diagenode SA
· Eisai Co., Ltd.
· F. Hoffmann-La Roche AG
· Illumina, Inc.
· MilliporeSigma
· Novartis International AG
· Oncolys BioPharma Inc.
· QIAGEN GmbH
· Syndax Pharmaceuticals, Inc.
· Thermo Fisher Scientific, Inc.
· Valirx Plc
· Zymo Research Corporation
Read the full report: https://www.reportlinker.com/p05817986/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Product Overview
Epigenetics: A Prelude
US to Dominate the Epigenetics Market
Global Competitor Market Shares
Epigenetics Competitor Market Share Scenario Worldwide (in %):
2019 & 2028
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prominence of Epigenetics Led Diagnostics
New Innovations and Techniques in Epigenetics
New Epigenetics Research Findings Creating Problems
4. GLOBAL MARKET PERSPECTIVE
Table 1: Epigenetics Global Market Estimates and Forecasts in
US$ Million by Region/Country: 2020-2027
Table 2: Epigenetics Global Retrospective Market Scenario in
US$ Million by Region/Country: 2012-2019
Table 3: Epigenetics Market Share Shift across Key Geographies
Worldwide: 2012 VS 2020 VS 2027
Table 4: Reagents (Product) World Market by Region/Country in
US$ Million: 2020 to 2027
Table 5: Reagents (Product) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019
Table 6: Reagents (Product) Market Share Breakdown of Worldwide
Sales by Region/Country: 2012 VS 2020 VS 2027
Table 7: Kits (Product) Potential Growth Markets Worldwide in
US$ Million: 2020 to 2027
Table 8: Kits (Product) Historic Market Perspective by
Region/Country in US$ Million: 2012 to 2019
Table 9: Kits (Product) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027
Table 10: Instruments (Product) Geographic Market Spread
Worldwide in US$ Million: 2020 to 2027
Table 11: Instruments (Product) Region Wise Breakdown of Global
Historic Demand in US$ Million: 2012 to 2019
Table 12: Instruments (Product) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027
Table 13: Enzymes (Product) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2020 to 2027
Table 14: Enzymes (Product) Market Historic Review by
Region/Country in US$ Million: 2012 to 2019
Table 15: Enzymes (Product) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027
Table 16: Services (Product) World Market by Region/Country in
US$ Million: 2020 to 2027
Table 17: Services (Product) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019
Table 18: Services (Product) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027
Table 19: DNA Methylation (Technology) World Market Estimates
and Forecasts in US$ Million by Region/Country: 2020 to 2027
Table 20: DNA Methylation (Technology) Market Worldwide
Historic Review by Region/Country in US$ Million: 2012 to 2019
Table 21: DNA Methylation (Technology) Market Percentage Share
Distribution by Region/Country: 2012 VS 2020 VS 2027
Table 22: Histone Methylation (Technology) Market Opportunity
Analysis Worldwide in US$ Million by Region/Country: 2020 to
2027
Table 23: Histone Methylation (Technology) Global Historic
Demand in US$ Million by Region/Country: 2012 to 2019
Table 24: Histone Methylation (Technology) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027
Table 25: Histone Acetylation (Technology) World Market by
Region/Country in US$ Million: 2020 to 2027
Table 26: Histone Acetylation (Technology) Historic Market
Analysis by Region/Country in US$ Million: 2012 to 2019
Table 27: Histone Acetylation (Technology) Market Share
Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
2027
Table 28: Large Non - Coding RNA (Technology) Potential Growth
Markets Worldwide in US$ Million: 2020 to 2027
Table 29: Large Non - Coding RNA (Technology) Historic Market
Perspective by Region/Country in US$ Million: 2012 to 2019
Table 30: Large Non - Coding RNA (Technology) Market Sales
Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
Table 31: MicroRNA Modification (Technology) Geographic Market
Spread Worldwide in US$ Million: 2020 to 2027
Table 32: MicroRNA Modification (Technology) Region Wise
Breakdown of Global Historic Demand in US$ Million: 2012 to
2019
Table 33: MicroRNA Modification (Technology) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027
Table 34: Chromatin Structures (Technology) World Market
Estimates and Forecasts by Region/Country in US$ Million: 2020
to 2027
Table 35: Chromatin Structures (Technology) Market Historic
Review by Region/Country in US$ Million: 2012 to 2019
Table 36: Chromatin Structures (Technology) Market Share
Breakdown by Region/Country: 2012 VS 2020 VS 2027
Table 37: Oncology (Application) Sales Estimates and Forecasts
in US$ Million by Region/Country for the Years 2020 through
2027
Table 38: Oncology (Application) Analysis of Historic Sales in
US$ Million by Region/Country for the Years 2012 to 2019
Table 39: Oncology (Application) Global Market Share
Distribution by Region/Country for 2012, 2020, and 2027
Table 40: Non - Oncology (Application) Global Opportunity
Assessment in US$ Million by Region/Country: 2020-2027
Table 41: Non - Oncology (Application) Historic Sales Analysis
in US$ Million by Region/Country: 2012-2019
Table 42: Non - Oncology (Application) Percentage Share
Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS
2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Epigenetics Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 43: United States Epigenetics Market Estimates and
Projections in US$ Million by Product: 2020 to 2027
Table 44: Epigenetics Market in the United States by Product:
A Historic Review in US$ Million for 2012-2019
Table 45: United States Epigenetics Market Share Breakdown by
Product: 2012 VS 2020 VS 2027
Table 46: Epigenetics Market in US$ Million in the United
States by Technology: 2020-2027
Table 47: United States Epigenetics Market Retrospective
Analysis in US$ Million by Technology: 2012-2019
Table 48: United States Epigenetics Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 49: United States Epigenetics Latent Demand Forecasts in
US$ Million by Application: 2020 to 2027
Table 50: Epigenetics Historic Demand Patterns in the United
States by Application in US$ Million for 2012-2019
Table 51: Epigenetics Market Share Breakdown in the United
States by Application: 2012 VS 2020 VS 2027
CANADA
Table 52: Canadian Epigenetics Market Estimates and Forecasts
in US$ Million by Product: 2020 to 2027
Table 53: Canadian Epigenetics Historic Market Review by
Product in US$ Million: 2012-2019
Table 54: Epigenetics Market in Canada: Percentage Share
Breakdown of Sales by Product for 2012, 2020, and 2027
Table 55: Epigenetics Market Analysis in Canada in US$ Million
by Technology: 2020-2027
Table 56: Epigenetics Market in Canada: Historic Review in US$
Million by Technology for the Period 2012-2019
Table 57: Canadian Epigenetics Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 58: Canadian Epigenetics Market Quantitative Demand
Analysis in US$ Million by Application: 2020 to 2027
Table 59: Epigenetics Market in Canada: Summarization of
Historic Demand Patterns in US$ Million by Application for
2012-2019
Table 60: Canadian Epigenetics Market Share Analysis by
Application: 2012 VS 2020 VS 2027
JAPAN
Table 61: Japanese Market for Epigenetics: Annual Sales
Estimates and Projections in US$ Million by Product for the
Period 2020-2027
Table 62: Epigenetics Market in Japan: Historic Sales Analysis
in US$ Million by Product for the Period 2012-2019
Table 63: Japanese Epigenetics Market Share Analysis by
Product: 2012 VS 2020 VS 2027
Table 64: Japanese Medium & Long-Term Outlook for Epigenetics
Market in US$ Million by Technology: 2020-2027
Table 65: Epigenetics Market in Japan in US$ Million by
Technology: 2012-2019
Table 66: Japanese Epigenetics Market Percentage Share
Distribution by Technology: 2012 VS 2020 VS 2027
Table 67: Japanese Demand Estimates and Forecasts for
Epigenetics in US$ Million by Application: 2020 to 2027
Table 68: Japanese Epigenetics Market in US$ Million by
Application: 2012-2019
Table 69: Epigenetics Market Share Shift in Japan by
Application: 2012 VS 2020 VS 2027
CHINA
Table 70: Chinese Epigenetics Market Growth Prospects in US$
Million by Product for the Period 2020-2027
Table 71: Epigenetics Historic Market Analysis in China in US$
Million by Product: 2012-2019
Table 72: Chinese Epigenetics Market by Product: Percentage
Breakdown of Sales for 2012, 2020, and 2027
Table 73: Epigenetics Market Estimates and Forecasts in China
in US$ Million by Technology: 2020-2027
Table 74: Chinese Epigenetics Retrospective Market Scenario in
US$ Million by Technology: 2012-2019
Table 75: Epigenetics Market in China: Percentage Share
Analysis by Technology for 2012, 2020, and 2027
Table 76: Chinese Demand for Epigenetics in US$ Million by
Application: 2020 to 2027
Table 77: Epigenetics Market Review in China in US$ Million by
Application: 2012-2019
Table 78: Chinese Epigenetics Market Share Breakdown by
Application: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Epigenetics Market: Competitor Market Share Scenario
(in %) for 2019 & 2025
Market Analytics
Table 79: European Epigenetics Market Demand Scenario in US$
Million by Region/Country: 2020-2027
Table 80: Epigenetics Market in Europe: A Historic Market
Perspective in US$ Million by Region/Country for the Period
2012-2019
Table 81: European Epigenetics Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027
Table 82: European Epigenetics Market Estimates and Forecasts
in US$ Million by Product: 2020-2027
Table 83: Epigenetics Market in Europe in US$ Million by
Product: A Historic Review for the Period 2012-2019
Table 84: European Epigenetics Market Share Breakdown by
Product: 2012 VS 2020 VS 2027
Table 85: European Epigenetics Market Assessment in US$ Million
by Technology: 2020-2027
Table 86: European Epigenetics Historic Market Review in US$
Million by Technology: 2012-2019
Table 87: Epigenetics Market in Europe: Percentage Breakdown of
Sales by Technology for 2012, 2020, and 2027
Table 88: European Epigenetics Addressable Market Opportunity
in US$ Million by Application: 2020-2027
Table 89: Epigenetics Market in Europe: Summarization of
Historic Demand in US$ Million by Application for the Period
2012-2019
Table 90: European Epigenetics Market Share Analysis by
Application: 2012 VS 2020 VS 2027
FRANCE
Table 91: Epigenetics Market in France by Product: Estimates
and Projections in US$ Million for the Period 2020-2027
Table 92: French Epigenetics Historic Market Scenario in US$
Million by Product: 2012-2019
Table 93: French Epigenetics Market Share Analysis by Product:
2012 VS 2020 VS 2027
Table 94: French Epigenetics Market Estimates and Projections
in US$ Million by Technology: 2020-2027
Table 95: French Epigenetics Historic Market Analysis in US$
Million by Technology: 2012-2019
Table 96: French Epigenetics Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 97: Epigenetics Quantitative Demand Analysis in France in
US$ Million by Application: 2020-2027
Table 98: French Epigenetics Historic Market Review in US$
Million by Application: 2012-2019
Table 99: French Epigenetics Market Share Analysis: A 17-Year
Perspective by Application for 2012, 2020, and 2027
GERMANY
Table 100: Epigenetics Market in Germany: Recent Past, Current
and Future Analysis in US$ Million by Product for the Period
2020-2027
Table 101: German Epigenetics Historic Market Analysis in US$
Million by Product: 2012-2019
Table 102: German Epigenetics Market Share Breakdown by
Product: 2012 VS 2020 VS 2027
Table 103: German Epigenetics Latent Demand Forecasts in US$
Million by Technology: 2020-2027
Table 104: Epigenetics Market in Germany: A Historic
Perspective by Technology in US$ Million for the Period
2012-2019
Table 105: German Epigenetics Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 106: Epigenetics Market in Germany: Annual Sales
Estimates and Forecasts in US$ Million by Application for the
Period 2020-2027
Table 107: German Epigenetics Market in Retrospect in US$
Million by Application: 2012-2019
Table 108: Epigenetics Market Share Distribution in Germany by
Application: 2012 VS 2020 VS 2027
ITALY
Table 109: Italian Epigenetics Market Growth Prospects in US$
Million by Product for the Period 2020-2027
Table 110: Epigenetics Historic Market Analysis in Italy in US$
Million by Product: 2012-2019
Table 111: Italian Epigenetics Market by Product: Percentage
Breakdown of Sales for 2012, 2020, and 2027
Table 112: Epigenetics Market Estimates and Forecasts in Italy
in US$ Million by Technology: 2020-2027
Table 113: Italian Epigenetics Retrospective Market Scenario in
US$ Million by Technology: 2012-2019
Table 114: Epigenetics Market in Italy: Percentage Share
Analysis by Technology for 2012, 2020, and 2027
Table 115: Italian Demand for Epigenetics in US$ Million by
Application: 2020 to 2027
Table 116: Epigenetics Market Review in Italy in US$ Million by
Application: 2012-2019
Table 117: Italian Epigenetics Market Share Breakdown by
Application: 2012 VS 2020 VS 2027
UNITED KINGDOM
Table 118: United Kingdom Market for Epigenetics: Annual Sales
Estimates and Projections in US$ Million by Product for the
Period 2020-2027
Table 119: Epigenetics Market in the United Kingdom: Historic
Sales Analysis in US$ Million by Product for the Period
2012-2019
Table 120: United Kingdom Epigenetics Market Share Analysis by
Product: 2012 VS 2020 VS 2027
Table 121: United Kingdom Medium & Long-Term Outlook for
Epigenetics Market in US$ Million by Technology: 2020-2027
Table 122: Epigenetics Market in the United Kingdom in US$
Million by Technology: 2012-2019
Table 123: United Kingdom Epigenetics Market Percentage Share
Distribution by Technology: 2012 VS 2020 VS 2027
Table 124: United Kingdom Demand Estimates and Forecasts for
Epigenetics in US$ Million by Application: 2020 to 2027
Table 125: United Kingdom Epigenetics Market in US$ Million by
Application: 2012-2019
Table 126: Epigenetics Market Share Shift in the United Kingdom
by Application: 2012 VS 2020 VS 2027
REST OF EUROPE
Table 127: Rest of Europe Epigenetics Market Estimates and
Forecasts in US$ Million by Product: 2020-2027
Table 128: Epigenetics Market in Rest of Europe in US$ Million
by Product: A Historic Review for the Period 2012-2019
Table 129: Rest of Europe Epigenetics Market Share Breakdown by
Product: 2012 VS 2020 VS 2027
Table 130: Rest of Europe Epigenetics Market Assessment in US$
Million by Technology: 2020-2027
Table 131: Rest of Europe Epigenetics Historic Market Review in
US$ Million by Technology: 2012-2019
Table 132: Epigenetics Market in Rest of Europe: Percentage
Breakdown of Sales by Technology for 2012, 2020, and 2027
Table 133: Rest of Europe Epigenetics Addressable Market
Opportunity in US$ Million by Application: 2020-2027
Table 134: Epigenetics Market in Rest of Europe: Summarization
of Historic Demand in US$ Million by Application for the Period
2012-2019
Table 135: Rest of Europe Epigenetics Market Share Analysis by
Application: 2012 VS 2020 VS 2027
ASIA-PACIFIC
Table 136: Epigenetics Market in Asia-Pacific by Product:
Estimates and Projections in US$ Million for the Period
2020-2027
Table 137: Asia-Pacific Epigenetics Historic Market Scenario in
US$ Million by Product: 2012-2019
Table 138: Asia-Pacific Epigenetics Market Share Analysis by
Product: 2012 VS 2020 VS 2027
Table 139: Asia-Pacific Epigenetics Market Estimates and
Projections in US$ Million by Technology: 2020-2027
Table 140: Asia-Pacific Epigenetics Historic Market Analysis in
US$ Million by Technology: 2012-2019
Table 141: Asia-Pacific Epigenetics Historic Market Analysis in
US$ Million by Technology: 2012 VS 2020 VS 2027
Table 142: Epigenetics Quantitative Demand Analysis in
Asia-Pacific in US$ Million by Application: 2020-2027
Table 143: Asia-Pacific Epigenetics Historic Market Review in
US$ Million by Application: 2012-2019
Table 144: Asia-Pacific Epigenetics Market Share Analysis:
A 17-Year Perspective by Application for 2012, 2020, and 2027
REST OF WORLD
Table 145: Rest of World Epigenetics Market Estimates and
Forecasts in US$ Million by Product: 2020 to 2027
Table 146: Rest of World Epigenetics Historic Market Review by
Product in US$ Million: 2012-2019
Table 147: Epigenetics Market in Rest of World: Percentage
Share Breakdown of Sales by Product for 2012, 2020, and 2027
Table 148: Epigenetics Market Analysis in Rest of World in US$
Million by Technology: 2020-2027
Table 149: Epigenetics Market in Rest of World: Historic Review
in US$ Million by Technology for the Period 2012-2019
Table 150: Rest of World Epigenetics Market Share Breakdown by
Technology: 2012 VS 2020 VS 2027
Table 151: Rest of World Epigenetics Market Quantitative Demand
Analysis in US$ Million by Application: 2020 to 2027
Table 152: Epigenetics Market in Rest of World: Summarization
of Historic Demand Patterns in US$ Million by Application for
2012-2019
Table 153: Rest of World Epigenetics Market Share Analysis by
Application: 2012 VS 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 39
Read the full report: https://www.reportlinker.com/p05817986/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001